Possible Value of Faecal Immunochemical Test (FIT) When Added in Symptomatic Patients Referred for Colonoscopy: A Systematic Review
- PMID: 37046672
- PMCID: PMC10093340
- DOI: 10.3390/cancers15072011
Possible Value of Faecal Immunochemical Test (FIT) When Added in Symptomatic Patients Referred for Colonoscopy: A Systematic Review
Abstract
If Colorectal cancer (CRC) is detected and treated early, the survival rate is high. This is one of the reasons that population-based screening programs for the early detection of CRC using the faecal immunochemical test (FIT) started worldwide. These programs compete with regular colonoscopy programs and increase the waiting time for symptomatic patients. However, the literature has shown that the correlation between intestinal complaints and the gain of colonoscopy is poor. The aim of this study is to assess the diagnostic utility of symptoms for the yield (CRC) of colonoscopy and to compare this with the diagnostic utility of FIT when offered to symptomatic patients.
Methods: We performed a systematic review search for CRC as an outcome of colonoscopy in referred symptomatic patients and separately for CRC as an outcome in symptomatic patients with a positive FIT. We searched systematically for clinical trials or observational studies in databases, followed by hand-searching of reference lists. We used random Meta-Disc to evaluate the diagnostic performance, using the exploration of heterogeneity with a variety of test statistics and by computing the pooled estimates.
Results: We included 35 studies, with almost 5 million symptomatic patients. In addition, we included nine prospective studies with a positive FIT in symptomatic patients, with more than 5000 patients. Significant heterogeneity was found for every symptom and the outcome of colonoscopy in the effect size of sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio. In a random effect model, the pooled sensitivity of colonoscopy in symptomatic patients was very low (25%). However, the pooled sensitivity in symptomatic patients with a positive FIT was 83% and the pooled specificity 77%. A total of 75 symptomatic patients (1.4%) had a false-negative FIT.
Conclusion: Adding FIT in symptomatic patients seems useful for predicting CRC as an outcome of colonoscopy. FIT seems a potential tool for an improved triage of colonoscopy in symptomatic patients.
Keywords: colorectal cancer; faecal immunochemical test (FIT); symptoms.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.World J Gastroenterol. 2020 Jan 7;26(1):70-85. doi: 10.3748/wjg.v26.i1.70. World J Gastroenterol. 2020. PMID: 31933515 Free PMC article.
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.Colorectal Dis. 2014 Aug;16(8):O273-82. doi: 10.1111/codi.12569. Colorectal Dis. 2014. PMID: 24456168
-
Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis.Gut. 2022 May;71(5):950-960. doi: 10.1136/gutjnl-2021-324856. Epub 2021 Jun 9. Gut. 2022. PMID: 34108236
-
Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.Acta Gastroenterol Belg. 2019 Apr-Jun;82(2):291-299. Acta Gastroenterol Belg. 2019. PMID: 31314191
Cited by
-
Utility of Stool-Based Tests for Colorectal Cancer Detection: A Comprehensive Review.Healthcare (Basel). 2024 Aug 18;12(16):1645. doi: 10.3390/healthcare12161645. Healthcare (Basel). 2024. PMID: 39201203 Free PMC article. Review.
-
The Value of Colonoscopy in Assessing Rectal Bleeding in Patients Referred From Outpatient Care Units in Erbil, Iraq.Cureus. 2024 Oct 20;16(10):e71911. doi: 10.7759/cureus.71911. eCollection 2024 Oct. Cureus. 2024. PMID: 39564041 Free PMC article.
-
Early Detection, Precision Treatment, Recurrence Monitoring: Liquid Biopsy Transforms Colorectal Cancer Therapy.Curr Cancer Drug Targets. 2025;25(6):586-619. doi: 10.2174/0115680096295070240318075023. Curr Cancer Drug Targets. 2025. PMID: 38623975 Review.
References
-
- Knottnerus J.A. Bevolkingsonderzoek naar darmkanker. Bijblijven. 2009;25:34–44.
-
- Van Veldhuizen-Eshuis H., Carpay M.E.M., van Delden J.A., Grievink L., Hoebee B., Lock A.J.J., Reij R. Uitvoeringstoets Bevolkingsonderzoek Darmkanker: Opsporing van Darmkanker in Praktijk Gebracht. National Institute for Public Health and the Environment; Bilthoven, MA, USA: 2011.
Publication types
LinkOut - more resources
Full Text Sources